Supplemental Grant Application Instructions II-2 . Scenario C. Exempt Human Subjects Research If all of the proposed human subjects research meets the criteria for one or more of the exemptions from the requirements in the HHS regulations (46.101(b)) (see Part III Section 3 under Human Subjects Research
Adults with one of the above listed conditions who have not received any pneumococcal vaccine should get a dose of PCV13 first and should also continue to receive the recommended doses of PPSV23. Ask your health care provider for details.
To date, use of MIF serology with Chlamydia pneumoniae (TWAR) antigen has provided the most sensitive and specific method for diagnosis of acute TWAR infection. In primary infections, the TWAR IgM antibody response is longer lasting and IgG antibody is slower to develop compared with Chlamydia trachomatis infection.